{
      "ptx_code": "PTX140",
      "chem_name": "1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-2H-Benzimidazol-2-one",
      "casrn": "2062-78-4",
      "dtxsid": "DTXSID8023474",
      "smiles": "FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1",
      "inchikey": "YVUQSNJEYSNKRX-UHFFFAOYSA-N",
      "label": "PTX140 | 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-2H-Benzimidazol-2-one",
      "drugbank_id": "DB01100",
      "use_class": "Pharmaceutical",
      "tox_class": "Hepatotoxicity; Cardiotoxicity",
      "chem_name_user": "Pimozide",
      "mw_g_mol": "461.56",
      "solubility_h2o_mol_liter": "2.19e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.07e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "6.36",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "11.50",
      "pka_base": "8.53",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "6.30",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "5.43",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "2.03e-03",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "0.70",
      "baseline_dmagna": "1.22",
      "baseline_celegans": "2.74",
      "baseline_xlaevis": "3.75",
      "baseline_dmelanogaster": "10.09",
      "baseline_cells": "5.80e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.18e-07",
      "moa_drugbank": "The ability of pimozide to suppress motor and phonic tics in Tourette's Disorder is thought to be primarily a function of its dopaminergic blocking activity. Pimozide binds and inhibits the dopamine D2 receptor in the CNS.",
      "protein_binding": "",
      "moa_t3db": "The ability of pimozide to suppress motor and phonic tics in Tourette's Disorder is thought to be primarily a function of its dopaminergic blocking activity. Pimozide binds to the dopamine D2 receptor in the CNS. It also appears to block voltage-operated calcium channels and acts as an antagonist at opiate receptors (OP2).",
      "aop": [],
      "targets": [
            "5-hydroxytryptamine receptor 1A",
            "5-hydroxytryptamine receptor 2A",
            "5-hydroxytryptamine receptor 2C",
            "5-hydroxytryptamine receptor 6",
            "Calmodulin",
            "Cytochrome P450 3A4",
            "D(1A) dopamine receptor",
            "D(2) dopamine receptor",
            "D(3) dopamine receptor",
            "Delta-type opioid receptor",
            "Kappa-type opioid receptor",
            "Mu-type opioid receptor",
            "Multidrug and toxin extrusion protein 1",
            "Multidrug and toxin extrusion protein 2",
            "Multidrug resistance protein 1",
            "Potassium voltage-gated channel subfamily H member 2",
            "Solute carrier family 22 member 2",
            "Voltage-dependent T-type calcium channel subunit alpha-1G"
      ]
}